Canada 001-32312 98-0442987 98-0442987 |
3560 Lenox Road, Suite 2000, Atlanta, GA 30326 |
• | do not reflect the company’s cash expenditures or requirements for capital expenditures or capital commitments; | ||
• | do not reflect changes in, or cash requirements for, the company’s working capital needs; and | ||
• | do not reflect any costs related to the current or future replacement of assets being depreciated and amortized. |
• | as measures of operating performance to assist the company in comparing its operating performance on a consistent basis because it removes the impact of items not directly resulting from the company’s core operations; | ||||
• | for planning purposes, including the preparation of the company’s internal annual operating budgets and financial projections; | ||||
• | to evaluate the performance and effectiveness of the company's operational strategies; and | ||||
• | to calculate incentive compensation payments for the company’s key employees. |
(d) | Exhibits. | |||
99.1 | Press release, dated November 10, 2014 (furnished to the Commission as a part of this Form 8-K). | |||
99.2 | Presentation materials, dated November 10, 2014 (furnished to the Commission as a part of this Form 8-K). | |||
NOVELIS INC. | ||||
Date: November 10, 2014 | By: | /s/ Leslie J. Parrette, Jr. | ||
Leslie J. Parrette, Jr. | ||||
General Counsel, Corporate Secretary and Compliance Officer |
Exhibit | |||
Number | Description | ||
99.1 | Press release, dated November 10, 2014 (furnished to the Commission as a part of this Form 8-K). | ||
99.2 | Presentation materials, dated November 10, 2014 (furnished to the Commission as a part of this Form 8-K). |
• | Net Income Increased 65% versus Prior Year to $38 Million |
• | Sales Increased 17% versus Prior Year to $2.8 Billion |
• | Adjusted EBITDA Increased 1% versus Prior Year to $230 Million |
• | Shipments Increased 7% versus Prior Year to 765 Kilotonnes |
• | Expanded its recycling operations in Brazil and commissioned the world's largest aluminum recycling facility in Germany; |
• | Grown total shipments through the ramp-up of new rolling capacity in Korea and Brazil; |
• | Become the only company able to produce automotive sheet in all three of the world's major automobile producing regions - Asia, Europe and North America - with the opening of China's first manufacturing facility for heat-treated aluminum automotive sheet. |
(in $M) | Q2FY15 | Q2FY14 | |||||
9/30/2014 | 9/30/2013 | ||||||
Free Cash Flow | $(108) | $178 | |||||
Capital Expenditures | 126 | 184 | |||||
Free Cash Flow before CapEx | $18 | $362 |
Media Contact: | Investor Contact: | |
Neil Hirsch | Megan Cochard | |
+1 404 760 4465 | +1 404 760 4170 | |
neil.hirsch@novelis.com | megan.cochard@novelis.com |
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Net sales | $ | 2,831 | $ | 2,414 | $ | 5,511 | $ | 4,815 | |||||||
Cost of goods sold (exclusive of depreciation and amortization) | 2,483 | 2,074 | 4,812 | 4,172 | |||||||||||
Selling, general and administrative expenses | 103 | 109 | 211 | 229 | |||||||||||
Depreciation and amortization | 90 | 79 | 179 | 156 | |||||||||||
Research and development expenses | 12 | 12 | 24 | 22 | |||||||||||
Interest expense and amortization of debt issuance costs | 82 | 75 | 163 | 151 | |||||||||||
Gain on assets held for sale | — | — | (11 | ) | — | ||||||||||
Restructuring and impairment, net | 7 | 18 | 13 | 27 | |||||||||||
Equity in net loss of non-consolidated affiliates | — | 3 | 2 | 7 | |||||||||||
Other expense (income), net | 18 | (5 | ) | 23 | (15 | ) | |||||||||
2,795 | 2,365 | 5,416 | 4,749 | ||||||||||||
Income before income taxes | 36 | 49 | 95 | 66 | |||||||||||
Income tax (benefit) provision | (2 | ) | 26 | 22 | 29 | ||||||||||
Net income | 38 | 23 | 73 | 37 | |||||||||||
Net income attributable to noncontrolling interests | — | — | — | — | |||||||||||
Net income attributable to our common shareholder | $ | 38 | $ | 23 | $ | 73 | $ | 37 |
September 30, 2014 | March 31, 2014 | ||||||
ASSETS | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 326 | $ | 509 | |||
Accounts receivable, net | |||||||
— third parties (net of uncollectible accounts of $4 as of September 30, 2014 and March 31, 2014) | 1,518 | 1,382 | |||||
— related parties | 60 | 54 | |||||
Inventories | 1,504 | 1,173 | |||||
Prepaid expenses and other current assets | 124 | 101 | |||||
Fair value of derivative instruments | 79 | 51 | |||||
Deferred income tax assets | 76 | 101 | |||||
Assets held for sale | 73 | 102 | |||||
Total current assets | 3,760 | 3,473 | |||||
Property, plant and equipment, net | 3,535 | 3,513 | |||||
Goodwill | 608 | 611 | |||||
Intangible assets, net | 611 | 640 | |||||
Investment in and advances to non–consolidated affiliates | 560 | 612 | |||||
Deferred income tax assets | 77 | 80 | |||||
Other long–term assets | |||||||
— third parties | 160 | 173 | |||||
— related parties | 10 | 12 | |||||
Total assets | $ | 9,321 | $ | 9,114 | |||
LIABILITIES AND SHAREHOLDER’S EQUITY | |||||||
Current liabilities | |||||||
Current portion of long–term debt | $ | 92 | $ | 92 | |||
Short–term borrowings | 1,044 | 723 | |||||
Accounts payable | |||||||
— third parties | 1,643 | 1,418 | |||||
— related parties | 53 | 53 | |||||
Fair value of derivative instruments | 96 | 60 | |||||
Accrued expenses and other current liabilities | |||||||
— third parties | 556 | 547 | |||||
— related party | — | 250 | |||||
Deferred income tax liabilities | 48 | 16 | |||||
Liabilities held for sale | — | 11 | |||||
Total current liabilities | 3,532 | 3,170 | |||||
Long–term debt, net of current portion | 4,340 | 4,359 | |||||
Deferred income tax liabilities | 344 | 425 | |||||
Accrued postretirement benefits | 612 | 621 | |||||
Other long–term liabilities | 256 | 271 | |||||
Total liabilities | 9,084 | 8,846 | |||||
Commitments and contingencies | |||||||
Shareholder’s equity | |||||||
Common stock, no par value; unlimited number of shares authorized; 1,000 shares issued and outstanding as of September 30, 2014 and March 31, 2014 | — | — | |||||
Additional paid–in capital | 1,404 | 1,404 | |||||
Accumulated deficit | (1,000 | ) | (1,073 | ) | |||
Accumulated other comprehensive loss | (194 | ) | (91 | ) | |||
Total equity of our common shareholder | 210 | 240 | |||||
Noncontrolling interests | 27 | 28 | |||||
Total equity | 237 | 268 | |||||
Total liabilities and equity | $ | 9,321 | $ | 9,114 |
Six Months Ended September 30, | |||||||
2014 | 2013 | ||||||
OPERATING ACTIVITIES | |||||||
Net income | $ | 73 | $ | 37 | |||
Adjustments to determine net cash (used in) provided by operating activities: | |||||||
Depreciation and amortization | 179 | 156 | |||||
Loss on unrealized derivatives and other realized derivatives in investing activities, net | 14 | 14 | |||||
Gain on assets held for sale | (11 | ) | — | ||||
Deferred income taxes | (18 | ) | (20 | ) | |||
Amortization of fair value adjustments | 6 | 6 | |||||
Equity in net loss of non–consolidated affiliates | 2 | 7 | |||||
(Gain) loss on foreign exchange remeasurement of debt | (3 | ) | 2 | ||||
Loss on sale of assets | 3 | 2 | |||||
Impairment charges | — | 8 | |||||
Amortization of debt issuance costs and carrying value adjustment | 13 | 13 | |||||
Other, net | (1 | ) | (2 | ) | |||
Changes in assets and liabilities including assets and liabilities held for sale (net of effects from divestitures): | |||||||
Accounts receivable | (187 | ) | 163 | ||||
Inventories | (369 | ) | 20 | ||||
Accounts payable | 295 | (213 | ) | ||||
Other current assets | (29 | ) | 39 | ||||
Other current liabilities | 27 | 10 | |||||
Other noncurrent assets | (2 | ) | (6 | ) | |||
Other noncurrent liabilities | (5 | ) | 12 | ||||
Net cash (used in) provided by operating activities | (13 | ) | 248 | ||||
INVESTING ACTIVITIES | |||||||
Capital expenditures | (264 | ) | (365 | ) | |||
Proceeds from sales of assets, net of transaction fees | 34 | — | |||||
Proceeds from the sale of assets, related party, net of transaction fees | — | 8 | |||||
Outflows from investments in and advances to non–consolidated affiliates, net | (11 | ) | — | ||||
Proceeds from settlement of other undesignated derivative instruments, net | 3 | 6 | |||||
Net cash used in investing activities | (238 | ) | (351 | ) | |||
FINANCING ACTIVITIES | |||||||
Proceeds from issuance of long-term and short-term borrowings | 198 | 76 | |||||
Principal payments of long-term and short-term borrowings | (126 | ) | (59 | ) | |||
Revolving credit facilities and other, net | 248 | 131 | |||||
Return of capital to our common shareholder | (250 | ) | — | ||||
Dividends, noncontrolling interest | (1 | ) | — | ||||
Debt issuance costs | — | (8 | ) | ||||
Net cash provided by financing activities | 69 | 140 | |||||
Net (decrease) increase in cash and cash equivalents | (182 | ) | 37 | ||||
Effect of exchange rate changes on cash | (1 | ) | — | ||||
Cash and cash equivalents — beginning of period | 509 | 301 | |||||
Cash and cash equivalents — end of period | $ | 326 | $ | 338 |
(in millions) | Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Net income attributable to our common shareholder | $ | 38 | $ | 23 | $ | 73 | $ | 37 | |||||||
Income tax benefit (provision) | 2 | (26 | ) | (22 | ) | (29 | ) | ||||||||
Interest, net | (80 | ) | (74 | ) | (160 | ) | (150 | ) | |||||||
Depreciation and amortization | (90 | ) | (79 | ) | (179 | ) | (156 | ) | |||||||
EBITDA | 206 | 202 | 434 | 372 | |||||||||||
Unrealized (losses) gains on change in fair value of derivative instruments, net | (1 | ) | 4 | — | (8 | ) | |||||||||
Realized gains (losses) on derivative instruments not included in segment income | — | 2 | (1 | ) | 4 | ||||||||||
Adjustment to eliminate proportional consolidation | (9 | ) | (8 | ) | (17 | ) | (19 | ) | |||||||
Loss on sale of fixed assets | (2 | ) | (1 | ) | (3 | ) | (2 | ) | |||||||
Gain on assets held for sale | — | — | 11 | — | |||||||||||
Restructuring and impairment, net | (7 | ) | (18 | ) | (13 | ) | (27 | ) | |||||||
Other income, net | (5 | ) | (5 | ) | (8 | ) | (8 | ) | |||||||
Adjusted EBITDA | $ | 230 | $ | 228 | $ | 465 | $ | 432 |
Six Months Ended September 30, | |||||||
2014 | 2013 | ||||||
Net cash (used in) provided by operating activities | $ | (13 | ) | $ | 248 | ||
Net cash used in investing activities | (238 | ) | (351 | ) | |||
Less: Proceeds from sales of assets | (34 | ) | (8 | ) | |||
Free cash flow | $ | (285 | ) | $ | (111 | ) | |
Ending cash and cash equivalents | $ | 326 | 338 |
September 30, | March 31, | ||||||
2014 | 2014 | ||||||
Cash and cash equivalents | $ | 326 | $ | 509 | |||
Availability under committed credit facilities | 408 | 511 | |||||
Total liquidity | $ | 734 | $ | 1,020 |
Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Net income attributable to our common shareholder | $ | 38 | $ | 23 | $ | 73 | $ | 37 | |||||||
Certain Items: | |||||||||||||||
Gain on assets held for sale | — | — | (11 | ) | — | ||||||||||
Restructuring and impairment, net | 7 | 18 | 13 | 27 | |||||||||||
Tax effect on Certain Items | (3 | ) | (4 | ) | (3 | ) | (6 | ) | |||||||
Net income attributable to our common shareholder, excluding Certain Items | $ | 42 | $ | 37 | $ | 72 | $ | 58 |
Selected Operating Results Three Months Ended September 30, 2014 | North America | Europe | Asia | South America | Other and Eliminations | Total | |||||||||||||||||
Adjusted EBITDA | $ | 76 | $ | 75 | $ | 36 | $ | 41 | $ | 2 | $ | 230 | |||||||||||
Shipments | |||||||||||||||||||||||
Rolled products - third party | 259 | 225 | 173 | 108 | — | 765 | |||||||||||||||||
Rolled products - intersegment | 1 | 9 | 13 | 8 | (31 | ) | — | ||||||||||||||||
Total rolled products | 260 | 234 | 186 | 116 | (31 | ) | 765 |
Selected Operating Results Three Months Ended September 30, 2013 | North America | Europe | Asia | South America | Other and Eliminations | Total | |||||||||||||||||
Adjusted EBITDA | $ | 70 | $ | 61 | $ | 41 | $ | 56 | $ | — | $ | 228 | |||||||||||
Shipments | |||||||||||||||||||||||
Rolled products - third party | 237 | 216 | 155 | 105 | — | 713 | |||||||||||||||||
Rolled products - intersegment | 1 | 9 | 1 | 3 | (14 | ) | — | ||||||||||||||||
Rolled products | 238 | 225 | 156 | 108 | (14 | ) | 713 |
Selected Operating Results Six Months Ended September 30, 2014 | North America | Europe | Asia | South America | Other and Eliminations | Total | |||||||||||||||||
Adjusted EBITDA | $ | 140 | $ | 154 | $ | 73 | $ | 96 | $ | 2 | $ | 465 | |||||||||||
Shipments | |||||||||||||||||||||||
Rolled products - third party | 507 | 460 | 351 | 217 | — | 1,535 | |||||||||||||||||
Rolled products - intersegment | 2 | 20 | 23 | 13 | (58 | ) | — | ||||||||||||||||
Total rolled products | 509 | 480 | 374 | 230 | (58 | ) | 1,535 |
Selected Operating Results Six Months Ended September 30, 2013 | North America | Europe | Asia | South America | Other and Eliminations | Total | |||||||||||||||||
Adjusted EBITDA | $ | 116 | $ | 131 | $ | 87 | $ | 98 | $ | — | $ | 432 | |||||||||||
Shipments | |||||||||||||||||||||||
Rolled products - third party | 474 | 441 | 312 | 194 | — | 1,421 | |||||||||||||||||
Rolled products - intersegment | 2 | 16 | 6 | 6 | (30 | ) | — | ||||||||||||||||
Total rolled products | 476 | 457 | 318 | 200 | (30 | ) | 1,421 |